Trastuzumab emtansine (T-DM1) in patients with HER2-positive metastatic breast cancer and brain metastases: exploratory final analysis of cohort 1 from KAMILLA, a single-arm phase IIIb clinical trial☆

2020336 citationsJournal Articlehybrid Open Access

Authors

ClinicalTrials.gov identifier: NCT01702571.

Good health and well-being

Published in: Annals of Oncology

Volume 31, Issue 10, pp. 1350-1358

Field-Weighted Citation Impact: 25.48